UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 26, 2017
BioTelemetry, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
|
000-55039 |
|
46-2568498 |
|
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
1000 Cedar Hollow Road |
|
19355 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (610) 729-7000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 26, 2017, the Board of Directors of BioTelemetry, Inc. (“The Company’) approved salary increases for certain of its executive officers, effective February 2, 2017 as follows:
|
|
|
|
|
Annual Base Salary |
| |
|
Name |
|
Title |
|
After Increase |
| |
|
|
|
|
|
|
| |
|
Joseph H. Capper |
|
President and Chief Executive Officer |
|
$ |
579,000 |
|
|
Heather Getz |
|
Senior Vice President, Chief Financial Officer |
|
$ |
359,000 |
|
|
Dan Wisniewski |
|
Senior Vice President, Technical Operations |
|
$ |
333,500 |
|
|
Peter Ferola |
|
Senior Vice President, General Counsel & Secretary |
|
$ |
324,500 |
|
|
Andy Broadway |
|
Senior Vice President, Sales and Marketing |
|
$ |
303,000 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
BioTelemetry, Inc. | |
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Peter F. Ferola |
|
|
|
Peter F. Ferola |
|
|
|
Senior Vice President and General Counsel |
|
|
|
|
Date: February 1, 2017